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SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform
interactions and activation by T-loop trans-autophosphorylation
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Mutations in the WNK [with no lysine (K) kinase] family instigate
hypertension and pain perception disorders. Of the four WNK
isoforms, much of the focus has been on WNK1, which is
activated in response to osmotic stress by phosphorylation of its
T-loop residue (Ser382). WNK isoforms phosphorylate and activate
the related SPAK (SPS1-related proline/alanine-rich kinase) and
OSR1 (oxidative stress-responsive kinase 1) protein kinases. In
the present study, we first describe the generation of double-
knockin ES (embryonic stem) cells, where SPAK and OSR1
cannot be activated by WNK1. We establish that NKCC1
(Na+ /K+ /2Cl− co-transporter 1), a proposed target of the WNK
pathway, is not phosphorylated or activated in a knockin that is
deficient in SPAK/OSR1 activity. We also observe that activity of
WNK1 and WNK3 are markedly elevated in the knockin cells,
demonstrating that SPAK/OSR1 significantly influences WNK
activity. Phosphorylation of another regulatory serine residue,
Ser1261, in WNK1 is unaffected in knockin cells, indicating that
this is not phosphorylated by SPAK/OSR1. We show that WNK
isoforms interact via a C-terminal CCD (coiled-coil domain) and
identify point mutations of conserved residues within this domain
that ablate the ability of WNK isoforms to interact. Employing
these mutants, we demonstrate that interaction of WNK isoforms
is not essential for their T-loop phosphorylation and activation,
at least for overexpressed WNK isoforms. Moreover, we finally
establish that full-length WNK1, WNK2 and WNK3, but not
WNK4, are capable of directly phosphorylating Ser382 of WNK1
in vitro. This supports the notion that T-loop phosphorylation of
WNK isoforms is controlled by trans-autophosphorylation. These
results provide novel insights into the WNK signal transduction
pathway and provide genetic evidence confirming the essential
role that SPAK/OSR1 play in controlling NKCC1 function. They
also reveal a role in which the downstream SPAK/OSR1 enzymes
markedly influence the activity of the upstream WNK activators.
The knockin ES cells lacking SPAK/OSR1 activity will be useful
in validating new targets of the WNK signalling pathway.
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INTRODUCTION
Mutations in the genes encoding WNK1 [with no lysine (K)
kinase-1] or WNK4 result in an inherited hypertension syndrome
termed Gordon’s syndrome or PHAII (pseudohypoaldosteronism
type II) [1]. Mutations within a neuronal-specific splice variant
of WNK1 have been shown to cause the hereditary sensory
neuropathy type II pain perception disorder [2,3]. All isoforms
of WNK possess an N-terminal kinase catalytic domain that is
unusual in that the catalytic lysine residue normally found in
subdomain II of most other kinases is replaced with another
lysine residue in subdomain I [4,5]. Other than an N-terminal
catalytic domain that is followed by an auto-inhibitory region,
which suppresses basal kinase activity [6] and 1–3 CCDs (coiled-
coil domains), the WNK isoforms contain no other obvious
functional domains (see Figure 3A). Furthermore, outside these
regions there is no significant sequence homology between WNK
isoforms.
The best-characterized WNK substrates comprise the closely
related and highly homologous STE20 kinase members SPAK
(SPS1-related proline/alanine-rich kinase) and OSR1 (oxidative
stress-responsive kinase 1), which are activated following
phosphorylation [7–9]. WNK isoforms interact with SPAK
as well as OSR1 and phosphorylate these enzymes at two
conserved residues, namely the T-loop threonine residue
(Thr233 in human SPAK) and the serine residue in the
S-motif (Ser373 in human SPAK) (reviewed in [10]). T-loop
phosphorylation triggers activation of SPAK and OSR1, whereas
the role of S-motif phosphorylation is unclear, as the mutation
of this residue does not affect SPAK or OSR1 activation [7,11].
SPAK and OSR1 kinases phosphorylate and activate members
of the electroneutral cation-coupled chloride co-transporters
(SLC12), including NCC (Na+ /Cl− co-transporter), NKCC1
(Na+ /K+ /2Cl− co-transporter 1) and NKCC2, which are targets
for the blood-pressure-lowering thiazide diuretic and loop diuretic
drugs [9,12–16]. Knockin mice expressing a form of SPAK
in which the T-loop residue is changed to alanine to prevent
activation by WNK isoforms have low blood pressure and reduced
phosphorylation of NCC in the kidney [17]. SPAK knockout mice
display a similar phenotype [18].
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The cellular activity of WNK1 is stimulated by hyperosmotic
or hypotonic low chloride conditions [11,19,20]. Phosphorylation
of a conserved serine residue present in all WNK isoforms
(Ser382 in WNK1) is required for activation of WNK1 [11]. The
isolated kinase domain of WNK1, when expressed in bacteria,
is phosphorylated at Ser382, suggesting that WNK isoforms are
capable of auto-phosphorylating this residue [6,11]. However, it
has not been demonstrated experimentally that WNK isoforms
can directly phosphorylate Ser382 in the T-loop of WNK1 in vitro.
Furthermore, kinase-inactive WNK1 is still phosphorylated at its
T-loop in vivo, raising the possibility that a distinct upstream
kinase mediates phosphorylation [11]. It has also been reported
that WNK isoforms interact with one another [20–23], but
whether this is required for WNK activation and/or SPAK/OSR1
phosphorylation is not known. Moreover, there is also controversy
regarding which regions mediate association of WNK isoforms,
with two reports suggesting that is mediated via the N-terminal
catalytic domain [20,21], whereas other studies have implicated
the C-terminal non-catalytic region [22,23].
In the present study we initially generated double knockin ES
(embryonic stem) cells expressing forms of SPAK and OSR1
that cannot be activated by WNK isoforms and employed these
to establish that SPAK/OSR1 regulate the phosphorylation and
activation of NKCC1 in vivo. We also found that the activity
of WNK1 and WNK3 is markedly elevated and not activated
further in response to osmotic stress in cells lacking SPAK/OSR1
activity, suggesting that SPAK/OSR1 can significantly influence
WNK isoform activity. We also provide evidence that the
ability of full-length WNK isoforms to interact is mediated
via a CCT (conserved C-terminal) coiled-coiled domain and
identify mutations that inhibit such interactions. In addition, we
demonstrate that full-length WNK1, WNK2 and WNK3, but not
WNK4, can directly phosphorylate the T-loop of WNK1 in vitro,
providing further evidence that WNK activity is regulated by a
trans-autophosphorylation reaction. Overall, these results provide
further information on the mechanism by which activity of WNK
isoforms is controlled.
MATERIALS AND METHODS
Materials
Sequencing-grade trypsin was from Promega. CompleteTM
protease inhibitor cocktail tablets were from Roche. Protein G–
Sepharose, glutathione–Sepharose and [γ -32P]ATP were from
Amersham Biosciences. Tween 20, Triton X-100 and dimethyl
pimelimidate were from Sigma-Aldrich. Colloidal Blue staining
kit and Precast SDS polyacrylamide Bis-Tris gels were from
Invitrogen. Phosphocellulose P81 paper was from Whatman. All
peptides were synthesized by Dr Graham Bloomberg (Molecular
Recognition Centre, University of Bristol School of Medical
Sciences, Bristol, U.K.).
General methods
Restriction enzyme digests, DNA ligations, generation of
knockin mouse ES cells, other recombinant DNA procedures,
electrophoresis, cell culture and transfections were performed
using standard protocols. All mutagenesis was performed using
the QuikChange site-directed mutagenesis method (Stratagene)
with KOD polymerase (Novagen). DNA constructs used for
transfection were purified from Escherichia coli DH5α using
QIAGEN kits according to the manufacturer’s protocol. All
DNA constructs were verified by DNA sequencing, which was
performed by the Sequencing Service (School of Life Sciences,
University of Dundee, Dundee, U.K.), using DYEnamic ET
terminator chemistry (GE Healthcare) on Applied Biosystems
automated DNA sequencers.
Antibodies
The antibodies against the following peptides were raised in sheep
and affinity-purified on the appropriate antigen by the Division of
Signal Transduction Therapy Unit at the University of Dundee:
WNK1 (residues 2360–2482 of human WNK1, S062B), WNK2
(residues 1605–1871 of human WNK2, S140C), WNK3 (residues
1142–1461 of human WNK3, S156C), WNK4 (residues 1221–
1243 of human WNK4, S064B), WNK2 mouse (residues 1650–
1808 of mouse WNK2, S385C), WNK3 mouse (residues 1145–
1508 of mouse WNK3, S346C). Validation of the specificity of
the human and mouse WNK isoform antibodies is presented
in Supplementary Figures S1 and S2 at http://www.BiochemJ.
org/bj/441/bj4410325add.htm). Additional antibodies were
against WNK1 pS382 [residues 375–389 of human WNK1 phos-
phorylated on Ser382, KRASFAK(P)SVIGTPEF, S099B], WNK1
pS1261 [residues 1254–1268 of human WNK1 phosphorylated
on Ser1261, AGRRFIV(P)SPVPESRL, S854B], SPAK mouse
(residues 439–453 of mouse SPAK, QSLSVHDSQAQPNAN,
S150C), OSR1 mouse (residues 389–408 of mouse OSR1,
SAHLPQPAGQMPTQPAQVSL, S149C), SPAK/OSR1 (T-loop)
phospho-Thr233/Thr185 [residues 226–238 of human SPAK or
residues 178–190 of human OSR1, TRNKVRK(P)TFVGTP,
S204C], SPAK/OSR1 (S-motif) phospho-Ser373/Ser325 [residues
367–379 of human SPAK, RRVPGS(P)SGHLHKT, which
is highly similar to residues 319–331 of human OSR1,
in which the sequence is RRVPGS(P)SGRLHKT, S670B],
NKCC1 phospho-Thr203, Thr207 and Thr212 [residues 198–217
of human NKCC1, HYYYD(P)THTN(P)TYYLR(P)TFGHNT,
S763B], NKCC1 total (residues 1–260 of shark NKCC1, S841B),
moesin (full-length human moesin, S135C) and GST (glutathione
transferase) (full-length bacterial GST, S902A). The anti-
FLAG antibody (F1804) was purchased from Sigma–Aldrich.
Secondary antibodies coupled to horseradish peroxidase used
for immunoblotting were obtained from Pierce. Pre-immune IgG
used in control immunoprecipitation experiments was affinity-
purified from pre-immune serum using Protein G–Sepharose.
Buffers
Buffer A contained 50 mM Tris/HCl, pH 7.5, 0.1 mM EGTA
and 1 mM DTT (dithiothreitol). Lysis buffer contained 50 mM
Tris/HCl, pH7.5, 1 mM EGTA, 1 mM EDTA, 1 mM Na3VO4,
50 mM NaF, 5 mM Na4P2O7, 0.27 M sucrose, 1% (v/v) Triton
X-100, 1 mM benzamidine, 0.1 mM PMSF and 1 mM DTT. TBS-
T contained 2 mM Tris/HCl, pH 7.5, 150 mM NaCl and 0.2%
Tween-20. SDS sample buffer contained 50 mM Tris/HCl, pH 6.8,
1% SDS, 1% (v/v) 2-mercaptoethanol and 6.5% glycerol.
Basic buffer contained 15 mM Hepes, pH 7.5, 135 mM NaCl,
5 mM KCl, 0.5 mM CaCl2, 0.5 mM MgCl2, 0.5 mM Na2HPO4
and 0.5 mM Na2SO4. Hypotonic low chloride buffer contained
7.5 mM Hepes, pH 7.5, 67.5 mM sodium gluconate, 2.5 mM
potassium gluconate, 0.25 mM CaCl2, 0.25 mM MgCl2, 0.5 mM
Na2HPO4 and 0.5 mM Na2SO4.
Cell culture, transient transfections and stimulations
HEK-293 (human embryonic kidney 293) cells were cultured on
10- or 15-cm-diameter dishes in DMEM (Dulbecco’s modified
Eagle’s medium) supplemented with 10% (v/v) fetal bovine
serum, 2 mM L-glutamine, 100 units/ml penicillin and 0.1 mg/ml
streptomycin. Non-transfected Flp-In T-Rex-HEK-293 cells were
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grown as normal HEK-293 cells; however, the medium was
supplemented with 100 μg/ml Zeocin and 15 μg/ml blasticidin.
Stable Flp-In T-Rex-HEK-293 cell lines were purchased from
Invitrogen and grown as normal HEK-293 cells; however,
the medium was supplemented with 15 μg/ml blasticidin and
100 μg/ml Hygromycin B. For HEK-293 transient transfection
experiments, each dish of adherent HEK-293 cells was transfected
with 20 μl of 1 mg/ml poly(ethylenimine) (Polysciences) and
5–10 μg of plasmid DNA as described previously [24]. Cells
were stimulated with either basic or hypotonic low chloride
or hypertonic conditions for 30 min. The cells were lysed in
0.3–0.75 ml ice-cold lysis buffer, the lysates were clarified by
centrifugation at 4 ◦C for 15 min at 26000 g and supernatants were
frozen in liquid nitrogen. Protein concentration was quantified
using the Bradford method [24a].
Generation of stable T-REx cell lines
Non-transfected Flp-In T-RExHEK-293 cells were co-transfected
with 0.5 μg of pcDNA5-FRT vector encoding FLAG-tagged
WNK isoforms and 4.5 μg of pOG44 Flp recombinase vector with
20 μl of 1 mg/ml polyethylenimine (Polysciences) as described
previously [24]. At 36 h post-transfection, the cells were put
under selection in medium containing 15 μg/ml blasticidin and
100 μg/ml Hygromycin B. Expression of the FLAG-tagged WNK
isoforms in the stable cell lines was induced by addition of 1 μg/ml
final concentration of doxycycline 12–24 h prior to harvesting.
Generation and genotyping of SPAK and OSR1 knockin ES cells
Mice were maintained under specific pathogen-free conditions in
accordance with the regulations set by the University of Dundee
and the U.K. Home Office. Female SPAK+ /T243A OSR1+ /T185A
mice were induced to superovulate by the injection of PMSG
(pregnant mare serum gonadotropin). This was followed 48 h
later by the injection of HCG (human chorionic gonadotropin).
These mice were then mated with male SPAK+ /T243A OSR1+ /T185A
mice. Blastocysts were removed at 2.5 days post-coitus and
cultured on 24-well plates on a feeder layer of mitotically
inactivated primary mouse embryonic fibroblasts for 1–2 weeks
to allow the ES cells to grow. Wells were trypsinized and
80% of the aliquot was frozen into two batches, whereas
the remaining 20% was used to grow cells for DNA prep-
aration. Cells were genotyped by PCR for SPAK and OSR1 [17].
Acquisition and genotyping of gene-trapped WNK3 knockout
ES cells
Mouse ES cells that were gene-trapped for WNK3 (gene trap
RRJ530) were purchased from the Gene Trap Consortium
(http://www.genetrap.org). As the WNK3 gene is located on
the X chromosome and ES cells obtained from the Gene Trap
Consortium are male XY cells, the prediction was that the
targeted WNK3 cells would lack expression of WNK3. WNK3
knockout cells were genotyped by PCR using the WNK3 forward
primer TGACATCAGGAACCTTAAAGACG and reverse primer
CCACCCTCAGTCCAGTATCC (Supplementary Figure S3
at http://www.BiochemJ.org/bj/441/bj4410325add.htm). These
primers detect the inserted fragment (500 bp) that was used to
disrupt expression of WNK3.
Immunoblotting
Cell lysates (20–40 μg), purified proteins or immunoprecipitates
in SDS sample buffer were subjected to electrophoresis on a
polyacrylamide gel and transferred to nitrocellulose membranes.
The membranes were incubated for 5 min with TBS-T containing
10% (w/v) non-fat dried skimmed milk powder. The membranes
were then immunoblotted in 5% (w/v) non-fat dried skimmed
milk powder in TBS-T with the indicated primary antibodies
for 2 h at room temperature. Sheep antibodies were used at
a concentration of 1–2 μg/ml, whereas commercial antibodies
were diluted 1000-fold. The incubation with phospho-specific
sheep antibodies was performed with the addition of 10 μg/ml of
the dephosphopeptide antigen used to raise the antibody. The
blots were then washed six times with TBS-T and incubated
for 45 min at room temperature with secondary horseradish
peroxidase-conjugated antibodies diluted 5000-fold in 5% (w/v)
non-fat dried skimmed milk powder in TBS-T. After repeating
the washing steps, the signal was detected with the enhanced
chemiluminescence reagent. Immunoblots were developed using
an automatic film processor (SRX-101; Konica Minolta Medical)
and films were scanned with a 300 dpi resolution on a scanner
(PowerLook 1000; UMAX). Figures were generated using
Photoshop/Illustrator (Adobe).
Expression and purification of WNK1 (1–667, D368A) and
full-length OSR1 in E. coli
All pGEX-6P-1 constructs were transformed into BL21 E. coli
cells, and 1 litre cultures were grown at 37 ◦C in Luria–Bertani
broth containing 100 μg/ml ampicillin until the attenuance at
600 nm was 0.8. Isopropyl β-D-thiogalactopyranoside (30 μM)
was then added and the cells were cultured for a further 16 h
at 26 ◦C. Cells were isolated by centrifugation at 26000 g,
resuspended in 40 ml of ice-cold lysis buffer and lysed in one
round of freeze/thawing, followed by sonication (Branson Digital
Sonifier; ten 15 s pulses with a setting of 45% amplitude) to
fragment DNA. Lysates were centrifuged at 4 ◦C for 15 min
at 26000 g. The GST-fusion proteins were affinity-purified on
0.5 ml of glutathione–Sepharose and eluted in buffer A containing
0.27 M sucrose and 20 mM glutathione. Alternatively, to cleave
GST, the resin was incubated overnight with GST-PreScission
protease (50 μg/0.5 ml beads).
Plasmids
Cloning of human WNK1 and human WNK4 have been described
previously [7]. In order to clone mouse WNK2 (NCBI accession
number NP_083637; residues 1650–1808) and mouse WNK3
(NCBI accession number: XP_914679; residues 1145–1508),
reverse transcription–PCR was carried out using mouse brain
RNA (Stratagene) as a template and the SuperScript III 1 Step
kit (Invitrogen). The resulting PCR products were digested
with BamHI/NotI restriction enzymes and then ligated into
pGex6 bacterial expression vector. The sequence was verified
by DNA Sequencing & Services (MRC Protein Phosphorylation
Unit, College of Life Sciences, University of Dundee, Scotland,
U.K.; http://www.dnaseq.co.uk) using Applied Biosystems Big-
Dye Version 3.1. The GST-tagged protein was purified in the
DSTT (Division of Signal Transduction Therapy, University of
Dundee, Dundee, U.K.) by standard methods. Required amino
acid mutations were introduced into the pCR2.1-TOPO clone
using site-directed mutagenesis with QuikChange® (Stratagene)
and sub-cloned into bacterial and mammalian expression vectors.
Purification of GST–WNK4 fragments
HEK-293 cells were transiently transfected with GST–WNK4
constructs and the cells were lysed in ice-cold lysis buffer 36 h
post-transfection. The lysates were clarified by centrifugation at
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4 ◦C for 15 min at 26000 g. The clarified lysates (1 mg) were
incubated with 5–10 μl glutathione–Sepharose beads for 1 h
at 4 ◦C. The beads were washed three times with lysis buffer
containing 0.5 M NaCl and 3 times with Buffer A. The purified
proteins were eluted in 1× SDS loading buffer and subjected to
immunoblotting with the anti-GST and anti-WNK1 antibodies.
Purification of FLAG–WNK isoforms
Expression of the WNK isoforms was induced 12–24 h prior to
harvest by addition of doxycycline to a final concentration of
1 μg/ml. The cells were stimulated with basic or hypotonic low
chloride buffers for 30 min and lysed in 0.3–0.75 ml ice-cold
lysis buffer. The lysates were clarified by centrifugation at 4 ◦C
for 15 min at 26000 g. The FLAG-tagged WNK isoforms were
affinity-purified by incubating 1 mg of clarified lysate with 5–
10 μl FLAG-agarose for 1 h at 4 ◦C. The beads were washed
three times with lysis buffer containing 0.5 M NaCl followed by
two washes with Buffer A. The purification was subsequently
either eluted in 1× SDS loading buffer or used for activity
measurements.
Gel filtration
HEK-293 cells or HEK-293 cells stably expressing wild-type or
mutant WNK4 were lysed in a low volume of lysis buffer to obtain
a protein concentration of >4 mg/ml and then centrifuged at
14000 g for 15 min to remove insoluble material. The supernatant
was filtered through a 0.2 μm filter and subjected to desalting
employing a GE Healthcare HiPrepTM 26/10 desalting column
equilibrated with 50 mM Tris/HCl, pH 7.5, 1 mM EGTA, 1 mM
EDTA, 0.1 mM PMSF, 1 mM benzamidine and 1 mM DTT. The
lysates were diluted to 6 mg/ml and 0.3 ml was injected on to a
GE Healthcare SuperoseTM 6 10/300 GL column equilibrated with
50 mM Tris/HCl, pH 7.5, 1 mM EGTA, 1 mM EDTA, 0.1 mM
PMSF, 1 mM benzamidine and 1 mM DTT at a flow rate of
0.5 ml/min and 0.2 ml fractions were collected. A total of 0.2 ml
of 2× SDS sample buffer was added to each fraction and the
fractions corresponding to molecular masses between the void
volume and 44 kDa were electrophoresed on a polyacrylamide
gel and immunoblotted with antibodies against WNK1, WNK3,
OSR1, SPAK and FLAG.
Assay of WNK activity towards OSR1
FLAG-tagged WNK isoforms were purified as described above.
The reaction mixture contained a final volume of 25 μl of Buffer
A containing 2 μg of OSR1 (D164A), 0.1 mM [γ -32P]ATP and
10 mM MgCl2. The reaction was performed in a Thermomixer at
30 ◦C for 30 min, and the reaction was terminated by addition of
5 μl of 5× SDS loading buffer. The samples were electrophoresed
on a polyacrylamide gel, which was stained with Colloidal Blue,
dried and autoradiographed.
Assay of WNK activity towards WNK1 Ser382
Immunoprecipitation of endogenous WNK1, WNK3 or
transfected FLAG-tagged WNK isoforms were undertaken as
described above. The reaction mixture contained a final volume
of 25 μl of Buffer A containing 1 μg of recombinant GST–
WNK1 (1–667, D368A) (expressed in E. coli), 0.1 mM ATP and
10 mM MgCl2. The reaction was performed in a Thermomixer at
30 ◦C for 20 min and the reaction was terminated by addition of
55 μl of 2× SDS loading buffer. Fractions of the samples were
electrophoresed on a polyacrylamide gel and immunoblotted with
anti-FLAG and anti-WNK1 phospho-Ser382 antibodies.
Immunoprecipitation and assay of OSR1
Clarified cell lysate (2 mg) was incubated with 5 μg of the
OSR1 (mouse peptide) antibody conjugated to 5 μl of Protein
G–Sepharose and incubated for 2 h at 4 ◦C with gentle agitation.
The immunoprecipitates were washed twice with 1 ml of lysis
buffer containing 0.5 M NaCl and twice with 1 ml of Buffer
A. The OSR1 immunoprecipitates were assayed with the
CATCHtide (cation chloride co-transporter peptide substrate)
(RRHYYYDTHTNTYYLRTFGHNTRR) that encompasses the
OSR1 phosphorylation sites on NKCC1 [15]. Assays were
set up in a total volume of 50 μl in Buffer A containing
10 mM MgCl2, 0.1 mM [γ -32P]ATP and 300 μM CATCHtide
(RRHYYYDTHTNTYYLRTFGHNTRR). After incubation for
30 min at 30 ◦C, the reaction mixture was applied onto P81
phosphocellulose paper, the papers were washed in phosphoric
acid, with the incorporation of 32P-radioactivity in CATCHtide
quantified by Cerenkov counting.
86Rb uptake NKCC1 assay
ES cells were plated in 12-well plates (2.4 cm diameter/well)
and the 86Rb uptake assay was performed on cells that were
80% confluent. Culture medium was removed from the wells
and replaced with either basic/isotonic or hypotonic/hypertonic
medium for 15 min at 37 ◦C. Cell medium was removed by
means of aspiration with a vacuum pump and replaced with
stimulating medium plus inhibitors including 1 mM ouabain
in the presence or absence of 0.1 mM bumetanide, an NKCC1
inhibitor, for a further 15 min. After this period, the medium
was removed and the cells were washed with basic/isotonic
medium to remove traces of hypo/hypertonic medium; next,
they were re-incubated with only basic/isotonic medium plus
inhibitors containing 2 μCi/ml 86Rb for 5 min at 37 ◦C. After this
incubation period, cells were rapidly washed three times with the
respective ice-cold non-radioactive medium. The cells were lysed
in 300 μl of ice-cold lysis buffer and 86Rb uptake tracer activity
was quantified on a PerkinElmer liquid scintillation analyser.
RESULTS
Generation of double knockin ES cells lacking SPAK and
OSR1 activity
We previously described the generation of knockin mice in
which the T-loop threonine residue in OSR1 (Thr185) and
SPAK (Thr243) was mutated to alanine in order to prevent
activation by WNK isoforms [17]. These mice were used to
generate single OSR1185A/185A, single SPAK243A/243A and double
OSR1185A/185A/SPAK243A/243A knockin ES cell lines as described
in the Materials and methods section. Similar levels of OSR1
protein expression were observed in wild-type and knockin ES
cell lines. Immunoblot analysis revealed no obvious expression
of SPAK protein in wild-type ES cells, suggesting that SPAK is
either not expressed or only present at very low levels in these cells
(Figures 1A and 1C). The wild-type and knockin ES cells were
stimulated under hypotonic low chloride conditions (Figure 1A)
or with sorbitol (Figure 1C) and OSR1 activity and T-loop
phosphorylation was assessed. In wild-type cells, hypotonic low
chloride (Figure 1A) and sorbitol (Figure 1C) induced significant
activation of OSR1, which was accompanied by phosphorylation
of Thr185. As expected, no detectable OSR1 activity or
phosphorylation at Thr185 was observed in the single OSR1185A/185A
or double OSR1185A/185A/SPAK243A/243A knockin ES cell lines
stimulated with hypotonic low chloride conditions (Figure 1A)
or sorbitol (Figure 1C). We also assessed the phosphorylation
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Figure 1 Evidence that SPAK/OSR1 regulate NKCC1 activity
(A) SPAK/OSR1 kinase-inactive mouse ES cells were stimulated with basic ( − ) or hypotonic low chloride ( + ) buffers and lysed. Wild-type (WT) (SPAK+ / + /OSR1+ / + ), single SPAK knockin (KI)
(SPAKT243A/T243A/OSR1+ / + ), single OSR1 knockin mice (SPAK+ / + /OSR1T185A/T185A) and double knockin (SPAKT243A/T243A/OSR1T185A/T185A) cells were used. OSR1 was immunoprecipitated (IP) from
the clarified lysates using the anti-OSR1 mouse peptide antibody. The immunoprecipitates were subjected to activity measurements using the CATCHtide [15]. A fraction of the immunoprecipitates
was also subjected to immunoblot assay with the indicated antibodies. (B) Confluent ES cells were incubated with either basic ( − ) or hypotonic low chloride ( + ) buffers for 30 min in the
presence of 1 mM ouabain (a known Na+ /K+ -ATPase inhibitor) and/or 0.1 mM bumetanide (a known NKCC1 inhibitor). 86Rb uptake proceeded for 5 min and was then quantified by scintillation
counting. Bumetanide-sensitive 86Rb uptake (i.e. bumetanide-insensitive counts subtracted) is plotted for both basic and hypotonic low chloride conditions. The anti-NKCC1 antibody was used to
immunoprecipitate NKCC1 from the ES cell extracts. The immunoprecipitates were subjected to immunoblot analysis using the indicated antibodies. (C) Same as (A) except that cells were stimulated
with isotonic [( − ), DMEM] and hyperosmotic [( + ), 0.5 M sorbitol] medium. (D) Same as (B), except that cells were stimulated with isotonic [( − ), DMEM] and hyperosmotic [( + ), 0.5 M
sorbitol] medium. The activity assay results are all presented as c.p.m. +− S.E.M. for triplicate samples. Statistical analyses were performed using the Student’s t test. P values listed above each bar
set refer to the comparison between non-stimulated and stimulated conditions for each ES cell type as well as a comparison of the wild-type stimulated with the stimulated single SPAK, OSR1 and
double knockin ES cells. Statistical significance was determined at P < 0.05. Molecular masses are indicated in kDa on the left-hand side of the Western blots. IB, immunoblot.
of NKCC1 at residues phosphorylated by SPAK/OSR1 (Thr197,
Thr201 and Thr206; numbering based on mouse sequence). This
revealed that in wild-type as well as single SPAK243A/243A
knockin ES cells, hypotonic low chloride conditions (Figure 1B)
or sorbitol (Figure 1D) induced marked phosphorylation of
NKCC1, accompanied by an increased ability to uptake 86Rb+
in a bumetanide (NKCC1 inhibitor)-sensitive manner. Strikingly,
no detectable NKCC1 phosphorylation or 86Rb+ bumetanide-
sensitive uptake was observed in the single OSR1185A/185A or double
OSR1185A/185A/SPAK243A/243A knockin ES cell lines (Figures 1B and
1D). The finding that NKCC1 phosphorylation and activity is
abolished in the single OSR1185A/185A ES cells also supports the
notion that SPAK is not significantly expressed in ES cells.
Increased WNK1 and WNK3 activity in OSR1185A/185A/SPAK243A/243A
knockin ES cells
We observed that the basal phosphorylation of OSR1 at the
S-motif residue (Ser325), which is phosphorylated by WNK
isoforms, was markedly elevated in the single OSR1185A/185A or
double OSR1185A/185A/SPAK243A/243A knockin ES cells and not fur-
ther increased by hypotonic low chloride (Figure 1A) or sorbitol
(Figure 1C). The degree of phosphorylation of OSR1 at Ser325
in knockin cells lacking OSR1 activity in control medium was
similar to phosphorylation observed in wild-type cells challenged
with osmotic stress (Figures 1A and 1C). These findings suggested
that WNK activity was markedly elevated in knockin ES cells
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Figure 2 SPAK/OSR1 suppresses WNK isoforms activity
(A) SPAK/OSR1 ES cells were treated with either basic ( − ) or hypotonic low-chloride ( + ) medium for 30 min. WNK1 was immunoprecipitated and its activity was assayed by employing
the kinase-inactive (KI) OSR1 (D164A) protein as a substrate. Phosphorylation of OSR1 was determined after electrophoresis followed by autoradiography of the Colloidal-Blue-stained bands
corresponding to OSR1. The incorporation of 32P radioactivity was also quantified and results are presented as the mean activity +− S.E.M. for duplicate samples. WNK1 immunoprecipitates were
also immunoblotted with the indicated antibodies. (B) Same as (A), except that cells were stimulated with isotonic [( − ), DMEM] or hyperosmotic [( + ), 0.5 M sorbitol] medium. (C) Endogenous
WNK3 was immunoprecipitated from SPAK/OSR1 ES cells treated with either basic ( − ) or hypotonic low-chloride ( + ) medium for 30 min and the activity was assayed employing kinase-inactive
OSR1 (D164A) as a substrate. WNK3 immunoprecipitates were also immunoblotted with the indicated antibodies. Statistical analyses were performed using the Student’s t test. P values listed above
each bar set refers to the comparison between non-stimulated and stimulated conditions for each ES cell type as well as a comparison of the wild-type stimulated with the stimulated single SPAK,
OSR1 and double knockin ES cells. Statistical significance was determined at P < 0.05. Molecular masses are indicated in kDa on the left-hand side of the Western blots. WT, wild-type.
lacking OSR1 activity. To verify this, we immunoprecipitated
endogenous WNK1 (Figures 2A and 2B) and WNK3 (Figure 2C)
from wild-type and knockin ES cells and assessed its activity
by monitoring its ability to phosphorylate OSR1 in vitro. This
revealed that, in the knockin cells lacking OSR1 activity, the
basal activity of WNK1 was increased ∼5-fold and that of WNK3
increased ∼2-fold compared with wild-type cells (Figure 2).
Evidence that SPAK/OSR1 do not regulate Ser1261 phosphorylation
of WNK1
Phosphorylation of WNK1 at Ser1261, which is located next to
a CCT domain binding RFXV motif (see the Introduction), is
thought to promote dissociation of SPAK/OSR1 from WNK1 after
these enzymes are activated by osmotic stress [10,11,15,26]. This
would enable the CCT domain of SPAK/OSR1 to interact with
substrates such as NKCC1 after these enzymes were activated
by WNK1. The kinase that mediates Ser1261 phosphorylation is
unknown, but it has been suggested that SPAK/OSR1 might
regulate Ser1261 phosphorylation, as this would represent a simple
system to couple the interaction of SPAK/OSR1 with WNK1
with the activation state of these enzymes [10]. To test this
hypothesis, we raised a phosphospecific antibody capable of
detecting phosphorylation of WNK1 at Ser1261. We found that
phosphorylation of Ser1261 in response to osmotic stress was not
affected by loss of SPAK/OSR1 activity in the knockin ES cells
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Figure 3 Endogenous WNK1 and WNK3 interact
(A) Schematic diagram of WNK isoform structures and the relative placement of their kinase
domain, auto-inhibitory domain (AID) and predicted CCDs, including the C-terminal CCD
(CT-CCD). (B) Lysates from HEK-293, WNK3 wild-type (WT) and WNK3 knockout (KO)
gene-trapped ES cells were subjected to immunoblot analysis with the indicated antibodies.
Recombinant WNK1–4 proteins were loaded as immunoblotting standards. (C) WNK1 and
WNK3 were immunoprecipitated from HEK-293, WNK3 wild-type (WT) and WNK3 knock-out
(KO) gene-trapped ES cell lysates. The preimmune IgG antibody was used as a negative control
for the immunoprecipitation assay. The immunoprecipitates were subjected to immunoblotting
using the indicated antibodies. Molecular masses are indicated in kDa on the left-hand side of
the Western blots. IP, immunoprecipitation.
(Figures 2A and 2B). This observation suggests that SPAK/OSR1
are not involved in controlling Ser1261 phosphorylation.
Evidence that endogenous WNK1 and WNK3 interact
Previous studies have shown that overexpressed WNK iso-
forms interact [20–23]. To demonstrate that endogenous WNK
isoforms associate, we raised antibodies specifically recognizing
the four WNK isoforms (Supplementary Figures S1 and S2).
Using these reagents, we found that endogenous WNK1 and
WNK3, but not WNK2 or WNK4, are readily detected in HEK-
293 and mouse ES cells (Figure 3B). We also acquired WNK3
knockout ES cells from the Gene Trap Consortium (see the
Materials and methods section) and showed that they expressed
similar levels of WNK1 as wild-type ES cells and also confirmed
the absence of WNK3 in these cells (Figure 3B). We observed
that WNK3 was indeed co-immunoprecipitated with endogenous
WNK1 in HEK-293 cells and wild-type ES cells, but not
in WNK3 knockout ES cells (Figure 3C). Conversely, WNK1
was co-immunoprecipitated with WNK3 in HEK-293 and wild-
type ES cells, but not in WNK3 knockout ES cells (Figure 3C).
Identification of key residues required for WNK isoform association
To investigate interaction of WNK isoforms in more detail,
we studied the binding of endogenous WNK1 to fragments of
the shortest WNK isoform (WNK4) overexpressed in HEK-293
cells (Figure 4A). These experiments revealed that a fragment
encompassing the isolated WNK4 C-terminal CCD (residues
1131–1167) interacted with endogenous WNK1 to a similar
extent as full-length WNK4. Fragments of WNK4 lacking the
C-terminal CCD failed to interact with WNK1 (Figure 4A). To
identify the critical residues within the C-terminal CCD required
for interaction with WNK1, we undertook an alanine scan, in
which the most highly conserved residues within this domain
were mutated to alanine. This revealed that mutation of His1145,
Glu1148 or Gln1156 markedly reduced interaction with endogenous
WNK1 (Figure 4B). Individual mutation of His1145 or Gln1156 in
full-length WNK4 drastically reduced its ability to interact with
endogenous WNK1 (Figure 4C). Moreover, mutation of both
His1145 and Gln1156 in full-length overexpressed WNK4 abolished
interaction with endogenous WNK1 (Figure 4D). His1145, Gln1148
and Gln1156 are conserved in the C-terminal CCDs of all WNK
isoforms (Figures 4E and 4F).
Evidence that WNK isoforms interact via their C-terminal CCD
We next generated HEK-293 cells that stably express full-length
forms of wild-type, kinase-inactive or ‘HQ mutant’ (residues
equivalent to His1145 or Gln1156 in WNK4 were mutated to alanine)
WNK2, WNK3 and WNK4. Using these cells, we confirmed
that endogenous WNK1 and WNK3 co-immunoprecipitated
with wild-type and kinase-inactive WNK2 (Figure 5A) or
WNK4 (Figure 5C). The HQ mutation in WNK2 (Figure 5A)
or WNK4 (Figure 5C) abolished interaction with endogenous
WNK1 and WNK3. Similarly, the HQ mutation in WNK3
abolished interaction with endogenous WNK1 (Figure 5B).
Stimulation of cells with hypotonic low chloride conditions to
induce activation of the WNK signalling pathway did not affect
association of WNK isoforms (Figure 5).
Gel filtration analysis of endogenous, WNK4 wild-type and WNK4
HQ isoforms
To analyse further the associations of the WNK isoforms, we
undertook gel filtration analysis of endogenous WNK1 and
WNK3 or stably overexpressed wild-type or HQ mutant WNK4
in HEK-293 cells (Figure 6). Consistent with the association
of WNK isoforms, we observed that endogenous WNK1 and
WNK3, as well as overexpressed WNK4, eluted at the high
molecular mass region of the gel filtration column between the
void volume and the 670 kDa marker (Figure 6). Minimal WNK1
and no WNK3 or WNK4 were detected in the fractions in which
a ∼250 kDa globular protein would be expected to elute. In
contrast, the bulk of the HQ-WNK4 mutant eluted at significantly
lower molecular mass fractions of the gel filtration column,
namely between the 670 and 158 kDa markers (Figure 6). A
fraction of the HQ-WNK4 mutant was found to elute at a high
molecular mass region of the column, indicating that HQ-WNK4
can associate with other interactors. We also immunoblotted for
endogenous SPAK and OSR1, and observed that these enzymes
migrated with a much lower apparent molecular mass, eluting
between the 158 kDa and 44 kDa markers.
Effect of HQ mutation on the ability of WNK isoforms
to phosphorylate OSR1
We next studied the intrinsic catalytic activity of each WNK
isoform by assessing their ability to phosphorylate OSR1 in vitro.
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Figure 4 WNK4 C-terminal CCD binds to WNK1
(A) HEK-293 cells were transfected with plasmids encoding the indicated GST fusion proteins. At 36 h after transfection, cells were lysed and the clarified lysate was incubated with GSH–Sepharose
to purify the GST-fusion proteins. Samples were then immunoblotted with the indicated antibodies. The position of the CCDs are indicated in the WNK4 schematic diagram above the Western blot. (B)
HEK-293 cells were transfected with GST–WNK4 (1131–1167) wild-type (WT), the indicated alanine residue mutant or GST. At 36 h after transfection, cells were lysed and GST affinity purifications
were performed. The purifications were probed for purified GST–WNK4 and co-purifying endogenous WNK1. (C) Same as (B), except that plasmids encoding full-length GST–WNK4 wild-type
or the alanine mutant H1145A and Q1156A were transfected in HEK-293 cells. (D) Purified GST–WNK4 wild-type or a double alanine mutant H1145A/Q1156A were transfected in HEK-293 cells.
(E) Alignment of the C-terminal CCD (CT-CCD) in the individual human WNK isoforms. The arrowheads point at the conserved histidine (His1145), glutamic acid (Glu1148) and glutamine (Gln1156)
residues. (F) A sequence alignment highlighting the conserved amino acids of the C-terminal CCD of the WNK isoforms in the indicated species; histidine, glutamic acid and glutamine.
Figure 5 The WNK isoforms dimerize via the C-terminal CCD
Stable Flp-In T-REx cell lines expressing wild-type (WT) and mutant forms of WNK2 (A), WNK3 (B) and WNK4 (C), including the kinase-inactive (KI) and HQ forms were stimulated with basic ( − )
or hypotonic low chloride ( + ) buffers and lysed. FLAG affinity purifications were performed on the clarified lysates and purifications were immunoblotted with the indicated antibodies. Moesin
levels were monitored as a loading control. IB, immunoblot; IP, immunoprecipitation.
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Figure 6 WNK isoforms exist in high molecular mass complexes
HEK-293 cell extract lysates or HEK-293 cell extracts expressing wild-type (WT) WNK4 or HQ mutant WNK4 that has lost ability to associate with other WNK isoforms were chromatographed on a GE
Healthcare SuperoseTM 6 10/300 GL gel-filtration column, and fractions were immunoblotted for the indicated WNK isforms or SPAK and OSR1. Stably overexpressed WNK4 and mutant HQ-WNK4
were detected with an anti-FLAG antibody as these enzymes possessed an N-terminal FLAG tag. The elution positions of the peak fractions of the globular protein standards thyroglobulin (670 kDa),
bovine γ -globulin (158 kDa) and chicken ovalbumin (44 kDa) are indicated at the top. Similar results were obtained in two separate experiments. The solid line between immunoblots indicates that
the samples were run on separate gels.
This revealed that the HQ mutants of WNK2 (Figure 7A), WNK3
(Figure 7B) as well as WNK4 (Figure 7C) isoforms were active, as
they phosphorylated OSR1 to a much greater extent than kinase-
inactive mutants (Figure 7). The residual activity observed with
the kinase-inactive mutants is likely to be due to association
with endogenous isoforms. This is supported by the finding
that a double kinase-inactive and HQ mutant of WNK4 failed
to significantly phosphorylate OSR1 (Figure 7C). The ability
of HQ mutant WNK2 (Figure 7A) and WNK3 (Figure 7B) to
phosphorylate OSR1 was modestly reduced compared with the
wild-type enzyme, which is likely to result from loss of association
with endogenous WNK1 and WNK3.
Osmotic stress promotes WNK1 activation by inducing
phosphorylation of the Ser382 T-loop residue [9,11]. The Ser382
residue as well as the surrounding amino acids are identical on
all WNK isoforms, indicating that the previously characterized
WNK1 phosphospecific Ser382 antibody [11] would recognize the
T-loop phosphorylated form of all the WNK isoforms and we
have confirmed this experimentally (Supplementary Figure S4
at http://www.BiochemJ.org/bj/441/bj4410325add.htm). To test
whether osmotic stress promoted T-loop phosphorylation of other
WNK isoforms, we investigated how hypotonic low chloride
conditions affected T-loop phosphorylation of WNK isoforms.
Hypotonic low chloride conditions induced a marked T-loop
phosphorylation of wild-type and HQ mutant WNK2 (Figure 7A),
WNK3 (Figure 7B) and WNK4 (Figure 7C). We also observed
that the kinase-inactive mutants present an increased basal T-loop
phosphorylation, modestly increased by hypotonic low chloride
conditions (Figure 7).
Effect of HQ mutation on the ability of WNK isoforms to
autophosphorylate
We next assessed the ability of immunoprecipitated WNK
isoforms to autophosphorylate when incubated with [γ -32P]ATP.
This revealed that the HQ mutants of WNK2 (Figure 7A),
WNK3 (Figure 7B) and WNK4 (Figure 7C) were phosphorylated
to a markedly lower extent than the wild-type enzymes.
No autophosphorylation of kinase-inactive WNK2 or WNK3
was observed. As reported previously [26], kinase-inactive
WNK4 autophosphorylated to a similar extent as the wild-type
protein (Figure 7C). Interestingly, the double kinase-inactive and
HQ mutant WNK4 mutant still became phosphorylated when
incubated with [γ -32P]ATP (Figure 7C), suggesting that a distinct
kinase activity associates with WNK4 specifically, which has also
been suggested by previous work [26].
WNK1, WNK2 and WNK3 but not WNK4 phosphorylate the T-loop
of WNK1 in vitro
Kinase-inactive WNK1 (1–667, D368A) expressed in E. coli,
which is not phosphorylated at Ser382 [11], was used to test
whether immunoprecipitated WNK isoforms can phosphorylate
Ser382 in vitro. We found that wild-type WNK2 (Figure 8A)
or WNK3 (Figure 8B) phosphorylated kinase-inactive WNK1
(1–667, D368A) at Ser382 in vitro. Consistent with this being
mediated by WNK isoforms directly rather than a contaminating
kinase, we observed that kinase-inactive WNK2 and WNK3
did not phosphorylate the WNK1 (1–667, D368A) at Ser382.
Immunoprecipitated endogenous WNK1 also phosphorylated the
WNK1 (1–667, D368A) fragment at Ser382, but stimulation with
high osmotic stress (0.5 M NaCl or 1 M sorbitol; 1000 m-osM)
was required to activate WNK1 in order to observe significant
phosphorylation of the WNK1 (1–667, D368A) fragment at Ser382
(Figure 8C). In contrast, wild-type WNK4, despite being able
to phosphorylate OSR1 (Figure 7C), failed to phosphorylate
the kinase-inactive WNK1 (1–667, D368A) fragment at Ser382
(Figure 8D). We also observed that the HQ WNK isoform mutants
phosphorylated WNK1 (1–667, D368A) at Ser382 to a slightly
lower extent than wild-type enzyme (Figure 8). This is likely
to result from the reduced association of these mutants with
other WNK isoforms that can also contribute to phosphorylation
of WNK1 (1–667, D368A) at Ser382.
DISCUSSION
To our knowledge, we have generated the first cell line that lacks
SPAK/OSR1 activity and used these to demonstrate that SPAK/
OSR1 activity does indeed play a crucial role in controlling
NKCC1 phosphorylation. This is emphasized by the complete
loss of phosphorylation of NKCC1 and the ability of the OSR1-
deficient knockin cells to uptake rubidium in a bumetanide-
dependent manner (Figure 1). These results provide the first
genetic evidence in mammalian cells that SPAK/OSR1 are
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Figure 7 Dimerization is important for autophosphorylation
Stable Flp-In T-Rex cell lines expressing wild-type (WT) and mutant forms of WNK2 (A), WNK3 (B) and WNK4 (C) including the kinase-inactive (KI) and HQ forms, were stimulated with basic ( − )
or hypotonic low chloride ( + ) buffers and lysed. The FLAG–WNK isoforms were affinity-purified and assayed for their activity towards the full-length kinase-dead OSR1 (D164A) (D/A) protein. The
top two panels are the resulting autoradiography and Coomassie Blue-stained gel labelled accordingly with the respective bands for the WNK isoforms and the GST–OSR1 substrate. In the bottom
panels, FLAG affinity purifications for the aforementioned assays were immunoblotted with the anti-WNK1 phospho-Ser382 antibody that recognizes the equivalent T-loop residue of WNK2, WNK3
and WNK4. Molecular masses are indicated in kDa on the left-hand side of the Western blots. IP, immunoprecipitation.
key regulators of NKCC1 function. We also observed that
WNK1 and WNK3 basal activity was markedly elevated in
the SPAK/OSR1-deficient ES cells as judged by significantly
increased phosphorylation of OSR1 at its S-motif Ser325 residue
(Figure 1) and increased kinase activity of immunoprecipitated
WNK1 and WNK3 (Figure 2). These observations provide the
first evidence that SPAK/OSR1 control WNK1 activity. One
possibility is that this is mediated through a regulatory negative
feedback network that is a common feature of many signal
transduction pathways. For example, in the MAPK (mitogen-
activated protein kinase) pathway, ERK1 (extracellular-signal-
regulated kinase 1)/ERK2 phosphorylate the upstream MEK
(MAPK/ERK kinase) [27], whereas RSK (ribosomal S6 kinase),
a kinase that is activated by ERK, phosphorylates and inhibits
mSOS (mammalian son of sevenless), the guanine nucleotide
exchange factor for Ras [28]. In the PI3K (phosphoinositide
3-kinase) pathway, S6K1 (S6 kinase 1) phosphorylates upstream
components such as IRS (insulin receptor substrate) adaptors
[29] and Rictor [30] to modulate overall PI3K pathway activity.
In the Parkinson’s disease LRRK2 (leucine-repeat-rich kinase
2) pathway, a downstream component of this network controls
LRRK2 phosphorylation, 14-3-3 binding and localization [31,32].
These regulatory feedback loops are inherent features of signal
transduction pathways and play crucial roles in modulating the
extent and duration of signalling networks. It is also possible
that the lack of NKCC1 activity in the SPAK/OSR1 knockin
cells results in these cells being inherently osmotically stressed,
leading to the constitutive activation of WNK1. In future studies
it will be important to define the molecular mechanism by
which WNK isoforms are controlled by SPAK/OSR1, as this
will shed more light into how the activity of the WNK enzymes
are regulated. However, our results emphasize that modulating
activity and/or expression of SPAK and OSR1 can have a major
impact on activity of their upstream WNK activators. This is also
important, as whole-genome association studies have identified
mutations that predispose to hypertension that link to the SPAK
gene and increase SPAK expression [33]. It would be interesting
to see whether these mutations also affected WNK isoform
activity and hence perhaps other downstream targets of these
enzymes. Pharmaceutical companies are developing inhibitors
of SPAK/OSR1 for the treatment of high blood pressure and the
prediction is that these drugs might elevate WNK isoform activity.
It would be important to appreciate the consequences of this in
future work.
We have extended previous work [20–23] by demonstrating
that endogenous WNK isoforms interact, and that the C-terminal
CCD mediates this association. Our findings are most consistent
with two of the earlier studies, namely that a fragment of
WNK4 (residues 399–1222, containing the C-terminal CCD)
interacts with full-length WNK4 in a yeast two-hybrid system [22]
and that a fragment of WNK4 (residues 445–1175, containing
the C-terminal CCD) bound a C-terminal fragment of WNK3
(residues 1243–1743, containing the C-terminal CCD) [23].
We have also shown that endogenous WNK1 and WNK3 as
well as overexpressed WNK4 migrate on gel filtration with an
apparent molecular mass of >670 kDa (Figure 6), in agreement
with the notion that these enzymes can stably associate with
each other. Consistent with this, we also find that the bulk of
the HQ-WNK4 mutant, which is unable to interact with other
WNK isoforms, migrates on gel filtration with a markedly lower
apparent molecular mass than wild-type isoforms (Figure 6). The
finding that a small fraction of the HQ-WNK4 mutant eluted at
an similar region to that of wild-type WNK4 indicates that WNK
isoforms may bind to other interactors in a manner not influenced
by the HQ mutation. The use of HQ mutants might simplify
future work to identify other interactors of WNK isoforms.
In future studies it would be important to identify these
components. Interestingly, despite SPAK and OSR1 binding to
RFXV motifs of WNK isoforms [15,25], we observed that SPAK
as well as OSR1 eluted at a much lower apparent molecular mass
region of the gel filtration column than WNK isoforms (Figure 6).
This demonstrates that either the bulk of cellular SPAK/OSR1
is not associated with WNK isoforms and/or the interactions
between WNK isoforms and SPAK/OSR1 are not sufficiently
robust to withstand the conditions of cell lysis and gel filtration.
The discovery of the HQ mutation, which abolishes association
of WNK isoforms, will be useful in future work to investigate
further the physiological importance of this interaction. Our initial
findings suggest that the interaction of WNK isoforms is not rate-
limiting in controlling the activation of WNK isoforms that have
been overexpressed in HEK-293 cells, as the non-associating HQ
mutants are activated in response to osmotic stress, albeit at a
moderately reduced level compared with wild-type (Figure 7).
The high degree of conservation of the C-terminal CCD in
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Figure 8 WNK2 and WNK3 can phosphorylate the T-loop of WNK1
Stable Flp-In T-REx cell lines expressing wild-type (WT) and mutant forms of WNK2 (A),
WNK3 (B) and WNK4 (D), including the kinase-inactive (KI) and His/Gln (HQ) forms, were
stimulated with basic ( − ) or hypotonic low chloride ( + ) buffers and lysed. The FLAG–WNK
isoforms were affinity purified and their activity towards Ser382 in GST–WNK1 (1–667, D368A)
was assayed. The reactions were immunoblotted with the antibodies indicated. The T-loop
phospho blot was undertaken using the anti-WNK1 phospho-Ser382 phosphospecific antibody
that cross-reacts with the phosphorylated T-loop of all WNK isoforms (see Supplementary
Figure S4 at http://www.BiochemJ.org/bj/441/bj4410325add.htm). The asterisk (*) marks an
unspecified band. (C) HEK-293 cells were either untreated or stimulated with hypotonic low
chloride, 500 m-osM (0.5 M) or 1000 m-osM (1 M) sorbitol, 500 m-osM (0.25 M) or 1000
m-osM (0.5 M) NaCl for 30 min. Endogenous WNK1 was immunoprecipitated from the lysates
and then subsequently assayed using a recombinant WNK1 (1–667, D368A) fragment as
substrate. The reaction was immunoblotted with the WNK1 phospho-Ser382 and GST antibodies.
The positive control was 1 ng of wild-type GST–WNK1 (1–667, D368A) expressed in E. coli,
which previous work has shown is constitutively phosphorylated at Ser382 [11]. Molecular
masses are indicated in kDa on the left-hand side of the Western blots. IP, immunoprecipitation.
all WNK isoforms and orthologues, including Caenorhabditis
elegans (Figures 4E and 4F), strongly suggests that this interaction
plays an important role. It should also be noted that our analysis of
the activation of the non-associating HQ-mutant WNK isoforms
was undertaken with overexpressed proteins. Endogenous levels
of WNK isoforms in cells are expressed at relatively low
levels and therefore their ability to interact with each other
may serve to enhance the efficiency in which they can trans-
autophosphorylate each other in response to osmotic stress.
Perhaps the best way to define the role these interactions play
would be to generate HQ-WNK mutant knockin mice or cells,
and investigate the impact on activation of WNK isoforms,
SPAK/OSR1 and blood pressure.
The activity of WNK isoforms is normally assessed after their
immunoprecipitation and the quantification of their ability to
phosphorylate a substrate such as OSR1. Alternatively, the ability
of immunoprecipitated WNK isoforms to autophosphorylate has
also been widely used as a reporter of WNK activity. The finding
that WNK isoforms associate complicates such in vitro analysis of
immunoprecipitated WNK activity, as the co-immunoprecipitated
associated WNK isoforms will also be capable of phosphorylating
substrates. Consistent with this, the HQ-WNK mutants displayed
reduced ability to phosphorylate OSR1 (Figure 7) as well as the
WNK1 (1–667, D368A) fragment at Ser382 (Figure 8). Many
groups have also investigated the ability of WNK isoforms to
undergo autophosphorylation when incubated with [γ -32P]ATP
[4,6,19,20,34]. As the ability of HQ mutants of WNK isoforms
to autophosphorylate is markedly diminished compared with
the wild-type protein (Figure 7), most of the phosphorylation
observed under these conditions probably results from the
association of WNK isoforms.
Osmotic stress induces the activation of WNK1 by inducing
its phosphorylation at Ser382 [6,11]. The results from the
present study demonstrate that osmotic stress also induces
phosphorylation of the equivalent T-loop residue of WNK2,
WNK3 and WNK4 isoforms (Figure 7). An unanswered question
is: how can cells sense osmotic stress and how does this
promote T-loop phosphorylation of the WNK isoforms? Studies
undertaken to date suggest that WNK1 possesses intrinsic ability
to autophosphorylate its own T-loop, as fragments of WNK1
that encompass the kinase domain when expressed in E. coli
are constitutively phosphorylated at Ser382 [6,11]. Consistent with
this, kinase-inactive WNK1 is not phosphorylated at Ser382 when
expressed in bacteria [11]. In the present study we provide
more evidence for this model by showing that three full-length
WNK isoforms (WNK1, WNK2 and WNK3) possess the intrinsic
ability to phosphorylate WNK1 at Ser382 in vitro (Figures 8A–
8C). These experiments provide further evidence that WNK
isoforms are capable of trans-autophosphorylating their own
T-loop residue. Kinase-inactive WNK1, when expressed in
HEK-293 cells, is phosphorylated normally at Ser382 in response
to osmotic stress [11], suggesting that overexpressed WNK1 can
be trans-autophosphorylated on its T-loop by endogenous WNK
isoforms. To date, no specific inhibitors of WNK isoforms have
been reported, although if such compounds were generated, it
would be fascinating to study how these affected the T-loop
phosphorylation and activation of the WNK isoforms. We also
observed that WNK4 was unable to phosphorylate the T-loop
residue of WNK1, despite being judged as active based on its
ability to phosphorylate SPAK/OSR1 (Figure 8D). Further work
is required to establish the physiological significance of this
observation.
It is vital that cells respond rapidly to osmotic stress before
they are irreversibly damaged. Indeed, WNK1 is phosphorylated
at Ser382 and activated within 30 s of cells being treated with
various osmotic shocks [11]. Perhaps the ability of WNK isoforms
to regulate their activity by autophosphorylation serves as a
simple and efficient system to enable WNK isoforms to be
switched on very quickly in response to osmotic stress and thereby
trigger responses that protect cells from becoming damaged. More
work is warranted to study this and to define how osmotic stress
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is detected and promotes trans-autophosphorylation of WNK
isoforms. WNK isoforms possess a long C-terminal region of
unknown function and it would be interesting to investigate
whether this domain is involved in sensing osmotic stress. It is also
possible that osmotic stress may inhibit the protein phosphatase
that acts on the T-loop of WNK isoforms. If WNK isoforms
auto-activated at a constant rate and osmotic stress inhibited
WNK phosphatase activity, this could also represent a simple
mechanism by which WNK isoforms could be rapidly switched
on. In future studies, it would be interesting to explore what
protein phosphatase(s) act on WNK isoforms, perhaps using
a focused phosphatase catalytic and regulatory subunit siRNA
(small interfering RNA)-based screening approach.
In summary, we have generated the first cell line that
lacks SPAK and OSR1 catalytic activity and use these
cells to demonstrate the vital role that SPAK/OSR1 play in
regulating NKCC1 activity. We also observe markedly increased
WNK1/WNK3 activity in the cells lacking SPAK/OSR1 activity,
indicating these STE20 kinases suppresses WNK isoform activity
either via a negative feedback loop or indirectly through inhibition
of NKCC1 activity, resulting in cells becoming osmotically
stressed. Our findings also provide further insights into the
molecular mechanism by which WNK isoforms are controlled.
We define how WNK isoforms interact and identify a simple
HQ-mutation that disrupts the self-association of WNK isoforms.
Studying the regulation and function of HQ-WNK mutants will be
useful in establishing the physiological role that this interaction
plays. Moreover, we provide further evidence that WNK isoforms
are regulated by trans-autophosphorylation by demonstrating for
the first time that WNK1, WNK2 and WNK3, but not WNK4,
can directly phosphorylate the T-loop of WNK1 in vitro. To
date, only three physiological substrates of SPAK/OSR1 have
been identified (NKCC1, NCC and NKCC2), and it is likely that
there will be many more substrates of these enzymes. No specific
inhibitors of SPAK/OSR1 or WNK isoforms have been developed
thus far, making it very hard to evaluate the physiological
functions of this signal transduction network. Identifying new
substrates of SPAK/OSR1 is important as it may reveal new
roles for the WNK signalling pathway. The availability of ES
cells lacking SPAK/OSR1 activity will be very useful in helping
to identify and validate new targets of the WNK–SPAK/OSR1
signalling network.
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SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform
interactions and activation by T-loop trans-autophosphorylation
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Figure S1 Specificity of human WNK isoform antibodies
(A) HEK-293 cells were untransfected or transfected with FLAG-tagged human WNK2, WNK3 and WNK4. Lysates (20μg) were subjected to immunoblot analysis with the indicated antibodies.
Moesin levels were monitored as a loading control. (B) Using the human FLAG–WNK-transfected cell lysates, immunoprecipitations with the individual antibodies were performed on each lysate as
indicated. The immunoprecipitations were next subjected to immunoblot analysis with the anti-FLAG antibody to check the specificity of the individual isoform immunoprecipitations. (C) HEK-293
lysates (20μg) were subjected to immunoblot analysis with the indicated isoform-specific antibodies. Lysates expressing the individual FLAG-tagged WNK isoforms were employed as a positive
control. Molecular masses are indicated in kDa on the left-hand side of the Western blots. IP, immunoprecipitation.
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Figure S2 Characterization of the mouse WNK2 and WNK3 antibodies
(A) Lysates (40μg) from a panel of mouse tissues and mouse cell lines were subjected to immunoblot analysis with the anti-WNK2 mouse antibody. (B) WNK2 was immunoprecipitated from mouse
brain lysates and probed with the anti-WNK2 mouse antibody. Immunoprecipitation with the preimmune IgG was used as a negative control. (C) Same as (A), except that the lysate panel of mouse
tissues and cell lines was immunoblotted with the anti-WNK3 mouse antibody. (D) WNK3 was immunoprecipitated using the mouse-specific WNK3 antibody from the indicated mouse tissues and
cell lines. The immunoprecipitates were subjected to immunoblot analysis with the WNK3 mouse-specific antibody. Molecular masses are indicated in kDa on the left-hand side of the Western blots.
IB, immunoblot; IP, immunoprecipitation; KO, knockout ES cells derived from the Gene Trap Consortium; mpkDCT, mouse-derived kidney distal-convoluted-tubule-derived cells; WT, wild-type.
Figure S3 ES cell genotyping
(A) Genomic DNA from the WNK3 wild-type and knockout ES cells was PCR amplified with the WNK3 primers described in the Materials and methods section of the main text. For the WNK3
knock-out, a 500 bp insert product used to disrupt the WNK3 gene is detected. (B) Genomic DNA from each SPAK/OSR1 ES wild-type, single and double cell line was PCR amplified with previously
reported SPAK and OSR1 primers [17]. For SPAK, the wild-type allele generates a 679 bp product, whereas the knockin allele generates a 587 bp product. For OSR1, the wild-type allele generates
a 290 bp product, whereas the knockin allele generates a 337 bp product. The larger knockin allele product is due to the presence of the 92 bp FRT site and flanking region, which remains in an
intronic region following Flp-mediated excision of the neomycin selection cassette. Molecular size (MW) markers are indicated in kb on the left-hand side of the gels.
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Figure S4 Characterization of the T-loop WNK isoform-specific antibody
HEK-293 cells were transfected with the indicated FLAG-tagged or GST-tagged WNK isoform
constructs encoding the wild-type (WT) and T-loop mutant in which the residue equivalent to
Ser382 in WNK1 is changed to an alanine residue to prevent activation (Ser356 in WNK2, Ser308
in WNK3 and Ser335 in WNK4). At 36 h post-transfection, the cells were lysed and whole cell
lysates (20μg) were subjected to immunoblot analysis with the indicated antibodies. Molecular
masses are indicated in kDa on the left-hand side of the Western blots.
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